CANDEL THERAPEUTICS, INC. Shares Outstanding (Cover Page)
CANDEL THERAPEUTICS, INC. (CADL) had Shares Outstanding (Cover Page) of 76.52 million shares as of 2026-08-06, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-06: Entity Common Stock, Shares Outstanding 76.52M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 73.27M shares.
- 2026-03-05: Entity Common Stock, Shares Outstanding 73.25M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 54.90M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 76.52M shares 10-Q · filed 2026-08-13 |
| 2026-05-07 | 73.27M shares 10-Q · filed 2026-05-14 |
| 2026-03-05 | 73.25M shares 10-K · filed 2026-03-12 |
| 2025-11-05 | 54.90M shares 10-Q · filed 2025-11-13 |
| 2025-08-05 | 54.90M shares 10-Q · filed 2025-08-14 |
| 2025-05-05 | 50.10M shares 10-Q · filed 2025-05-13 |
| 2025-03-06 | 47.24M shares 10-K · filed 2025-03-13 |
| 2024-11-04 | 32.48M shares 10-Q · filed 2024-11-14 |
| 2024-08-05 | 32.08M shares 10-Q · filed 2024-08-13 |
| 2024-05-06 | 29.74M shares 10-Q · filed 2024-05-14 |
| 2024-03-21 | 29.35M shares 10-K/A · filed 2024-04-25 |
| 2023-11-01 | 28.92M shares 10-Q · filed 2023-11-09 |
| 2023-08-02 | 28.92M shares 10-Q · filed 2023-08-10 |
| 2023-05-03 | 28.92M shares 10-Q · filed 2023-05-11 |
| 2023-03-15 | 28.92M shares 10-K/A · filed 2023-05-01 |
| 2022-11-02 | 28.89M shares 10-Q · filed 2022-11-10 |
| 2022-07-31 | 28.89M shares 10-Q · filed 2022-08-05 |
| 2022-05-04 | 28.69M shares 10-Q · filed 2022-05-12 |
| 2022-03-15 | 28.69M shares 10-K · filed 2022-03-29 |
| 2021-10-31 | 28.69M shares 10-Q · filed 2021-11-12 |
| 2021-08-31 | 28.69M shares 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |